Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay Levy, Roger Abramino
2004
114 5-6 p. 573-577
5 p.
artikel
2 Antibody-mediated interference with annexins in the antiphospholipid syndrome Rand, Jacob H.
2004
114 5-6 p. 383-389
7 p.
artikel
3 Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome Crowther, Mark A.
2004
114 5-6 p. 443-446
4 p.
artikel
4 Anti-β2-glycoprotein I antibodies—When and how should they be measured? Reber, Guido
2004
114 5-6 p. 527-531
5 p.
artikel
5 Antiphospholipid antibodies and fetal compromise Branch, D. Ware
2004
114 5-6 p. 415-418
4 p.
artikel
6 Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk? Galli, Monica
2004
114 5-6 p. 597-601
5 p.
artikel
7 Anti-phospholipid antibodies (aPL) and apoptosis: prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells Rauch, Joyce
2004
114 5-6 p. 371-382
12 p.
artikel
8 Antiprothrombin antibodies—are they worth assaying? Atsumi, Tatsuya
2004
114 5-6 p. 533-538
6 p.
artikel
9 Author Index - Vols. 113-114 2004
114 5-6 p. 677-684
8 p.
artikel
10 B cell biology, apoptosis, and autoantibodies to phospholipids Cook, Matthew C.
2004
114 5-6 p. 307-319
13 p.
artikel
11 Beta 2 glycoprotein I-function in health and disease Miyakis, Spiros
2004
114 5-6 p. 335-346
12 p.
artikel
12 Consensus guidelines for anticardiolipin antibody testing Wong, Richard C.W.
2004
114 5-6 p. 559-571
13 p.
artikel
13 Controversies in the antiphospholipid syndrome and stroke Gatenby, Paul A.
2004
114 5-6 p. 483-488
6 p.
artikel
14 Coronary and valvular syndromes and antiphospholipid antibodies Cervera, Ricard
2004
114 5-6 p. 501-507
7 p.
artikel
15 Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant Exner, Thomas
2004
114 5-6 p. 547-552
6 p.
artikel
16 Editorial Board 2004
114 5-6 p. IBC-
1 p.
artikel
17 β2-Glycoprotein I and LDL-receptor family members de Groot, Philip G.
2004
114 5-6 p. 455-459
5 p.
artikel
18 β2-glycoprotein I, anti-β2-glycoprotein I, and fibrinolysis Yasuda, Shinsuke
2004
114 5-6 p. 461-465
5 p.
artikel
19 β2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity Kuwana, Masataka
2004
114 5-6 p. 347-355
9 p.
artikel
20 Growth and function of the normal human placenta Gude, Neil M.
2004
114 5-6 p. 397-407
11 p.
artikel
21 Haemostatic changes in pregnancy Brenner, Benjamin
2004
114 5-6 p. 409-414
6 p.
artikel
22 How much warfarin is enough in APS related thrombosis? Erkan, Doruk
2004
114 5-6 p. 435-442
8 p.
artikel
23 ICAA Abstracts 2004
114 5-6 p. 603-675
73 p.
artikel
24 Immunologic manipulation for the threatened fetus Benson, Elizabeth M.
2004
114 5-6 p. 427-434
8 p.
artikel
25 Inflammatory response and the endothelium Meroni, P.L.
2004
114 5-6 p. 329-334
6 p.
artikel
26 Instructions to Authors 2004
114 5-6 p. I-III
nvt p.
artikel
27 Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies Pierangeli, Silvia S.
2004
114 5-6 p. 467-476
10 p.
artikel
28 Keyword Index - Vols. 113-114 2004
114 5-6 p. 685-688
4 p.
artikel
29 Libman–Sacks endocarditis associated with antiphospholipid syndrome and infection Blank, M.
2004
114 5-6 p. 589-592
4 p.
artikel
30 Management of the neurological manifestations of APS—what do the trials tell us? Brey, Robin L.
2004
114 5-6 p. 489-499
11 p.
artikel
31 Mechanisms of autoantibody-induced monocyte tissue factor expression Wolberg, Alisa S.
2004
114 5-6 p. 391-396
6 p.
artikel
32 Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies Tincani, Angela
2004
114 5-6 p. 553-558
6 p.
artikel
33 Peripheral vascular disease in antiphospholipid syndrome Vlachoyiannopoulos, Panayiotis G.
2004
114 5-6 p. 509-519
11 p.
artikel
34 Phenotyping the haemostatic system by thrombography—potential for the estimation of thrombotic risk Regnault, Véronique
2004
114 5-6 p. 539-545
7 p.
artikel
35 Platelet physiology and thrombosis Andrews, Robert K.
2004
114 5-6 p. 447-453
7 p.
artikel
36 Primary, Secondary, Catastrophic Antiphospholipid Syndrome: is there a difference? Harris, E. Nigel
2004
114 5-6 p. 357-361
5 p.
artikel
37 Tests for lupus anticoagulant revisited Derksen, Ronald H.W.M.
2004
114 5-6 p. 521-526
6 p.
artikel
38 The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases Youinou, Pierre
2004
114 5-6 p. 363-369
7 p.
artikel
39 The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation–reduction reactions McIntyre, John A.
2004
114 5-6 p. 579-587
9 p.
artikel
40 The impact of the inflammatory response on coagulation Esmon, Charles T.
2004
114 5-6 p. 321-327
7 p.
artikel
41 The interface of multiple sclerosis and antiphospholipid antibodies Chapman, Joab
2004
114 5-6 p. 477-481
5 p.
artikel
42 The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort Petri, Michelle
2004
114 5-6 p. 593-595
3 p.
artikel
43 Treatment of antiphospholipid syndrome in pregnancy—a systematic review of randomized therapeutic trials Lassere, Marissa
2004
114 5-6 p. 419-426
8 p.
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland